Omicron variant soon available!

On 26th of November 2021, WHO named B.1.1.529 as Omicron and designated it a variant of concern, on the basis on an advice from WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). Omicron has several mutations impacting it’s behaviour, which is rigorously studied across the globe.

We are also keeping up with the virus by producing SARS-CoV-2 Omicron variant (B.1.1.529) as Trimeric Spike, S1 and RBD. Furthermore, we will have Omicron version of Nucleocapsid protein available with P13L, del31-33, R203K and G204R mutations.

As we have successfully produced functional Spike proteins for all the variants of concern and have built up a high demand for our Omicron variant as well, then please, let us know if you are interested, so we can put you on a list to receive the variants first hand!